Skip to main content

Newborn

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bilim Pharmaceuticals
Bilim PharmaceuticalsTurkey - Istanbul
1 program
Baby MassageN/A1 trial
Active Trials
NCT06269458Completed60Est. Dec 2023
Medtronic
MedtronicNJ - Phillipsburg
1 program
OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring SystemN/A1 trial
Active Trials
NCT06637917Completed120Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
MedtronicOxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System
Bilim PharmaceuticalsBaby Massage

Clinical Trials (2)

Total enrollment: 180 patients across 2 trials

NCT06637917MedtronicOxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System

Pulse Oximetry Performance Comparison in Newborns

Start: Sep 2024Est. completion: Sep 2025120 patients
N/ACompleted

The Effects of Mother-Baby Yoga and Baby Massage on Attachment and Sleep

Start: Jan 2023Est. completion: Dec 202360 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.